Delivery Order SPE2DR25D6038-SPE2DR26F95KF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,276.80 to AmerisourceBergen Drug Corp for Risperdal 0.5 mg tablets (60-count) on October 27, 2025, with completion scheduled for October 28, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Risperdal 0.5 mg tablets (60-count) under a firm fixed price contract valued at $2,391.54. This is a non-set-aside competitive award with an ultimate completion date of December 8, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,188.80 to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 0.5 mg, a pharmaceutical product used in the treatment of psychiatric conditions. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 8, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's ability to...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,675.13 firm fixed-price delivery order for 60 tablets of Risperdal 0.5 mg on December 1, 2025, with completion due by December 2, 2025. This is a non-set-aside award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $2,523.74 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 0.5 mg on September 3, 2025, with completion targeted for September 4, 2025. The contract, which carries no set-aside designation, was competitively awarded on a firm fixed-price basis. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate office location in the same municipality. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Risperdal 4 mg tablets (60-count units) with a firm fixed price ceiling value of $2,526.04. The order was competitively awarded without set-aside designation and is scheduled for completion by November 21, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $12,175.63 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Risperdal 2 mg tablets in quantities of 60 units. This competitively awarded, firm fixed-price contract includes performance through September 11, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract carries no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a $3,855.14 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 0.5 mg on November 26, 2025, with an ultimate completion date of November 28, 2025. This non-set-aside delivery order utilizes firm fixed price terms and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a $1,110.06 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperidone 0.25 mg, with an ultimate completion date of October 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the vendor's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Risperdal 0.5 mg tablets (60 count) with a ceiling value of $3,787.60. This competitively awarded, firm fixed-price delivery order is set to be completed by August 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical...
- SPE2DR25D6038Indefinite Delivery Contract
- SPE2DR25D6038-SPE2DR26F95KFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,094.34 to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 0.5 mg, a pharmaceutical product used in neurological and psychiatric treatment. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and requires delivery by December 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a leading pharmaceutical distributor to federal healthcare systems, AmerisourceBergen serves as a critical prime vendor for the Defense Health Agency, U.S. Coast Guard, and other government medical supply chains, delivering an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic categories to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/4/25 |